Drugs / bacillus Calmette-Guerin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02175420 | Jul 2012 → Apr 2015 | — | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bacillus Calmette-Guerin | “The BCG (bacillus Calmette-Guerin) vaccine is used for the protection against tuberculosis.” NCT02175420 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02175420 ↗ |
| Modality | Vaccine | “BCG, the vaccine against tuberculosis” PMID 32065303 ↗ Feb 2020 |